Pharmaceutical market entry in Africa, de-risked before you commit capital
Entering African pharmaceutical markets is a commercial decision with regulatory consequences. Veltrion assesses your entry, names the real risks, and gives you one accountable local counterpart from evaluation through to execution.
What a Veltrion market-entry assessment covers
Regulatory pathway and timelines
The realistic route and timeline to register and operate in each target market, across SAHPRA, NAFDAC, TMDA, PPB and BoMRA.
Market access and pricing landscape
Who pays, how products are reimbursed or procured, and what access actually requires in each market.
Local representation requirements
Whether you need a local entity, licence holder or authorised representative, and how to structure it.
Execution risk and capital sequencing
Where capital is most at risk, and the order of moves that protects it.
Common questions
Which African markets do you cover?
We are active across Southern, East and West Africa and are regulator-fluent with SAHPRA (South Africa), NAFDAC (Nigeria), TMDA (Tanzania), PPB (Kenya) and BoMRA (Botswana), among others.
Is this advice or execution?
Both. The assessment is the entry point, but Veltrion is an execution partner, not an advisory shop. We do the work you can act on and remain your accountable counterpart through representation and activation.
How quickly can we start?
Most engagements begin with a scoping call and a defined, milestone-based assessment. Book a call and you will hear back within one business day.
Tell us where you are.
Pick the step that fits, give us the brief, and you will hear back from Wilhelm within one business day.
International pharma, biotech, medtech and nutraceutical companies ready to move from intent to operating presence. We reply by hand, fast, and name your real risk before price is ever discussed.